Episode 10: COVID-19 Vaccines: Three Leading Candidates, Assessed

In this episode, the TN team discuss three promising vaccine candidates being developed for COVID-19. We take a deep dive into the data from these vaccine trials to try and work out what successes can be celebrated and what unanswered questions still remain.

Read more from this podcast: 

Vaccine 1: Moderna's mRNA-1273

Vaccine 2: Oxford University's ChAdOx1

Vaccine 3: CanSino Biologics' Adenovirus Type-5

Antigen vs Antibody – What Are the Differences?

A Vaccine 101

Exploring the Drug Development Process

Moderna's COVID-19 Vaccine Shows Positive Interim Results in Phase I Trial